New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) - Related Studies

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

This study has been completed.

Study NCT00035854. Last updated on July 2, 2007. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bacterial Infections

2	Additional conditions recognized in this trial
		Communicable Diseases
		Infection

3	Interventions listed in this trial
		Zyvox® / Linezolid

4	Additional drug interventions recognized in this trial
		Linezolid

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Synthesis Inhibitors
		Therapeutic Uses

6	Sponsors listed in this trial
		Pfizer